A globomycin-resistant mutant of Escherchia coli was found to produce a precursor of the major outer membrane lipoprotein (prolipoprotein), in which the glycine residue at position 14 within the signal peptide was replaced by an aspartic acid residue. The same mutation has been reported by Lin et al. (Proc. Natl. Acad. Sci. U.S. A. 175:4891-4895, 1978). The structural gene of the mutant prolipoprotein was inserted into an inducible expression cloning vehicle. When the mutant prolipoprotein was produced in lipoprotein-minus host cells, 82% of the unprocessed protein was found in the membrane fraction, with the remaining 18% localized in the soluble fraction. However, when the production of the mutant prolipoprotein was induced in the wild-type lpp+ host cells, only 31% of the mutant prolipoprotein was found in the membrane fraction, leaving the remaining 69% in the soluble, cytoplasmic fraction. In addition, the assembly of the wild-type lipoprotein in these cells was not affected, whether the mutant prolipoprotein was produced or not. These results suggest that secretions of both mutant and wild-type prolipoproteins utilize the same component(s) responsible for the initial stages of secretion across the cytoplasmic membrane. However, it appears that the wild-type lipoprotein has a higher affinity for these components than does the mutant lipoprotein.
The major outer membrane lipoprotein of Escherichia coli is initially produced as a highermolecular-weight precursor, prolipoprotein, which has a 20-amino-acid signal peptide at its amino-terminal end (for a review see reference 3). Since its gene has been cloned and extensive study of its biogenesis has been achieved, this lipoprotein provides an ideal system for studying the molecular mechanisms involved in protein secretion across the membrane, as well as the assembly mechanism of membrane proteins (3) .
One of the approaches for studying protein secretion is to isolate mutants in the signal peptide. A mutant of the signal peptide of the prolipoprotein has been isolated, in which the glycine residue at position 14 is replaced by an aspartic acid residue (8) . As a result of this mutation, the following abnormal effects on the secretion, processing, and assembly of the lipoprotein were observed: (i) translocation of the mutant lipoprotein across the cytoplasmic mem-brane, (ii) assembly of about 80% of the unprocessed mutant precursor into the outer membrane fraction, (iii) lack of any glyceride modification of the cysteine residue at position 21 of the mutant prolipoprotein, and (iv) a fraction of the unmodified mutant prolipoprotein remaining within the cytoplasm.
In the present paper, we have independently isolated the identical mutant as a globomycinresistant mutant. The structural gene for the mutant (4), and after solubilization it was treated with anti-lipoprotein serum (6) . The immunoprecipitates were then applied to SDS-polyacrylamide gel electrophoresis by using the phosphate buffer system (5). This buffer system was used to separate the unmodified prolipoprotein from the mature (fully modified) lipoprotein, which cannot be achieved by using a Tris-hydrochloride buffer system (5 use of a phosphate buffer system (5) instead of a Tris-hydrochloride buffer system (band a in lane 2 of Fig. 1 ). The mature (fully modified) lipoprotein migrates faster than the unmodified prolipoprotein with this buffer system at the position indicated by an arrow in Fig. 1. ( iv) The mutant prolipoprotein was found to be localized not only in the outer membrane (65%) but also in the cytoplasmic membrane (5%), the periplasmic space (5%), and the cytoplasm (25%).
These results indicate that mutant Y16 is very similar to the lipoprotein mutant isolated by Lin et al. (8) , in which the glycine residue at position 14 of the prolipoprotein was altered to an aspartic acid residue. To examine this possibility, the Ipp gene of mutant Y16 was cloned into an expression cloning vector, pIN-II-Al (12) . The cloning was carried out as shown in Fig. 2 . Y16 DNA was cleaved with HindIII, and fragments of approximately 10 kilobases (kb) were purified by agarose gel electrophoresis. The 10-kb fragments were then digested with XbaI to isolate the 7.1-kb XbaI-HindIII fragments carrying the Y16 lpp gene. The existence of the lpp gene in these fractions was detected by Southern blot hybridization with use of a 32P-labeled DNA fragment derived from the wild-type lpp gene as a probe. The same probe was also used to detect transformants which carried the clone of the 7.1-kb XbaI-HindIII fragment.
Since there is an XbaI site immediately upstream of the Shine-Dalgarno sequence (ribosome-binding site) of the lpp gene (11), the 7.1-kb XbaI-HindIII fragment carries the lpp gene from downstream of the Shine-Dalgarno sequence, including the entire coding region and the 3'-end untranslated region, but not the lpp promoter or the 5'-end untranslated region. On the other hand, pIN-II-A vectors carry the lpp promoter, the entire 5'-end untranslated region, including the unique XbaI site, the initiation codon, and a coding region for a few amino acid residues followed by three restriction sites for EcoRI, HindIII, and BamHI (12) . In pIN-I1 vectors, an inducible lac promoter-operator fragment is inserted downstream of the lpp gene so that expression of a DNA fragment cloned into one of the restriction sites is under the control of both the Ipp promoter and the lac promoter-operator. In the present study, a small fragment from XbaI to HindIII of pIN-Il-A was replaced with a 7.1-kb XbaI-HindIII fragment.
The clone thus isolated was designated as pNL16 and was proven to carry the lpp gene, since cross-reactive materials with anti-lipoprotein serum were detected upon induction with isopropyl-p-D-thiogalactoside (IPTG; Sigma Chemical Co. (Fig. 3, a Amounts of the Y16 prolipoprotein and the wild-type lipoprotein were estimated by a densitometric tracing of Fig. 3 . The amount of the Y16 prolipoprotein thus obtained was corrected by a factor of 0.67 since it contains three methionine residues in contrast to the two methionine residues in the wild-type lipoprotein. All amounts are expressed as relative ratios to the amount of the wild-type lipoprotein in JE5506 lpp+(F' lacIq/pNL16) in the absence of IPTG (Fig. 3, lane 2) . The (10) .
In contrast to Y16 prolipoprotein, the assembly of the wild-type lipoprotein in the membrane was not affected at all by the concomitant production of Y16 prolipoprotein since there was no decrease in the amount of the wild-type lipoprotein assembled in the membrane fraction of E. coli JE5506 lpp+(F' lacP) in the presence of IPTG (Table 1) .
These results indicate that even if the mutant prolipoprotein appears to be abnormally assembled in the outer membrane, both the mutant prolipoprotein and the wild-type prolipoprotein are translocated across the cytoplasmic membrane through a common pathway at least in the early stages of secretion. However, the wildtype prolipoprotein is considered to have much higher affinity for the common secretory machinery than does the mutant prolipoprotein. At present, it is not known what composes the secretory machinery and what role it plays in protein secretion. However, it may be a component(s) in or on the cytoplasmic membrane required for the early association of the secretory precursor molecule via its signal peptide with the cytoplasmic membrane. 
